Products

What will AGI do for Amquinate?

This classification denotes an antiprotozoal agent with the molecular formula C18H24N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 21N28Z70CI, chemically known as 3-quinolinecarboxylic acid, 7-(diethylamino)-4-hydroxy-6-propyl-, methyl ester but generally known as amquinate, which bears US NIH Compound Identifier 28414. European Medicines Agency schedules Amquinate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05492MIG. The term AMQUINATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 23, No. 10 1969, List 9). AMQUINATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule amquinate under HS 29334910 and SITC 51575. As of Q4 2014, AMQUINATE remains the US FDA Preferred Term for this commodity. Amquinate bears US NLM identifiers UMLS ID C0601306 and NCI Concept Code C90754. SMILES: O=C1C2C([NH]CC1C(=O)OC)CC(N(CC)CC)C(CCC)C2.